Splenorenal Anastomosis (Splenorenal Anas Tomosis)

Splenorenal Anas Tomosis is a surgical procedure used to treat portal hypertension. It consists of creating an anastomosis (connection) between the splenic vein and the left renal vein.

This allows some of the blood from the portal system to be diverted directly into the systemic circulation, bypassing the liver. This reduces portal pressure and reduces complications of portal hypertension, such as bleeding from varices of the esophagus and stomach.

The main indication for splenorenal anastomosis is portal hypertension with preserved liver function. This method is preferable to portocaval anastomosis, as it preserves the normal hepatotropic function of the spleen and does not disrupt liver metabolism. However, it is technically more difficult to implement.

Thus, splenorenal anastomosis is an effective method of surgical treatment of portal hypertension, allowing to improve the hemodynamics of the portal system and prevent the development of life-threatening complications.

Splanrenal anastomosis is a method of treating portal hypertension, which involves connecting the splenic and left renal veins. This improves blood circulation in the liver and reduces pressure in the portal system.

Splanchrenal anastomosis differs from portacaval anastomosis, which connects the hepatic and inferior vena cava. With a splanchrenal anastomosis, the splenic vein connects to the left renal vein, and not to the inferior vena cava. This is more physiological, since the spleen and kidney are in close proximity to each other.

The benefits of splanchnic anastomosis include improved blood supply to the liver, decreased portal pressure, and a reduced risk of developing esophageal and gastric varices. However, this treatment method has its own risks and limitations, such as the possibility of blood clots and infection.

Overall, splanchnic anastomosis is an effective treatment for portal hypertension and can be used in patients at high risk of complications. However, before undergoing surgery, it is necessary to conduct a thorough examination and evaluate the risks and benefits of this method.

Splenorenal anastomosis, also known as a splenorenal shunt, is a treatment for portal hypertension that is used to reduce the pressure in the portal vein. This method involves connecting the splenic vein to the left renal vein.

Portal hypertension is a condition in which the pressure in the portal vein increases, leading to the development of cirrhosis, ascites and other complications. Splenorenal anastomosis is one of the methods of treating portal hypertension and can be used in cases where other methods of treatment are ineffective.

Splenorenal anastomosis involves creating a connection between the splenic vein and the left renal vein. This allows blood passing through the splenic vein to bypass the liver and head towards the heart, passing through the left renal vein. This process reduces the pressure in the portal vein and reduces the risk of developing complications of portal hypertension.

In comparison, portocaval anastomosis is another treatment for portal hypertension that involves creating a connection between the portal vein and the inferior vena cava. This method also diverts the blood passing through the portal vein bypassing the liver and reduces the pressure in the portal vein. However, portacaval anastomosis is a more complex and invasive procedure than splenorenal anastomosis and may be associated with greater risks of complications.

Although splenorenal anastomosis is a less complex procedure, it can also have its own risks and complications. Some of the possible complications may include bleeding, infection, thrombosis, and blood clots in the veins. Therefore, it is important to carefully discuss all possible risks and benefits of this procedure with your doctor before undergoing it.

Overall, splenorenal anastomosis is a treatment for portal hypertension that may be effective in certain cases. It is a simpler and less invasive procedure than a portacaval anastomosis, but can also have its own risks and complications. Patients considering this treatment should discuss all possible risks and benefits with their doctor to make an informed decision about their treatment.